Dr. Javier Ivanova

Radiation oncologist · Johns Hopkins · United States (US) · Oncology

Tier 1STK-0048GoodOwner MSL JWJames Whitfield

Data minimisation

Consent status: Recorded. The name shown may be a pseudonym. Contact details, personal identifiers and remuneration fields are hidden for your role; only scientific-profile fields needed for engagement planning are displayed.

Specialty: Thoracic oncology
Disease interests: SCLC, NSCLC
Scientific interests: irAE management
Engagement preference: In person
Advisory boards: 2
Publications: 70
Source system: Veeva CRM
Data quality: Good

Engagement plan

Cadence target for Tier 1: 4 per year (assumption)

Last engaged: 10 Aug 2026 (36 days ago)
Next planned contact: 09 Nov 2026
Last 6 months vs target: 100%
3 of 2 expected engagements

Insights from this stakeholder (1)

INS-0076Chemotherapy-free first line
12 Aug 2026 · Treatment pathway
MediumAction in progress

Engagement history (3)

All engagements including drafts, newest first

Date	Type	Format	MSL	Product	Topics	Insights	Flags	Status
10 Aug 2026	Scientific exchange	Virtual	James Whitfield	Vantrexa	Chemotherapy-free first line	1	MI request	Reviewed	ENG-0068
04 Jul 2026	Advisory board	In person	James Whitfield	Vantrexa	Elderly / ECOG 2 patientsBrain-metastasis subgroup data+1	0	—	Reviewed	ENG-0116
23 Mar 2026	Scientific exchange	Phone	James Whitfield	Vantrexa	Brain-metastasis subgroup dataInfusion-reaction management	0	—	Reviewed	ENG-0109

Timeline

10 Aug 2026
Scientific exchange
Chemotherapy-free first line
04 Jul 2026
Advisory board
Elderly / ECOG 2 patients, Brain-metastasis subgroup data, Infusion-reaction management
23 Mar 2026
Scientific exchange
Brain-metastasis subgroup data, Infusion-reaction management

Related stakeholders (5)

Johns Hopkins

Dr. Daniel Weber
Thoracic medical oncologist
Tier 1
Dr. Mariana Vogel
Primary care physician
Tier 3
Dr. Javier Ueda
General neurologist
Tier 2
Dr. Andrea Olsen
Allergist
Tier 2
Dr. Rosa Eriksen
Dermatologist
Tier 1